FNR Award for precision medicine

On 20 October 2022, the Luxembourg National Research Fund (FNR) presented the FNR Awards to reward exceptional contributions to science in Luxembourg. During the ceremony, Prof. Rejko Krüger, head of the Translational Neuroscience group at the LCSB and director for Transversal Translational Medicine at the Luxembourg Institute of Health (LIH), and Dr Ibrahim Boussaad, researcher at the LCSB, received the 2022 FNR Award for Outstanding Scientific Achievement.

The award was attributed to the two scientists and their team for the first proof-of-concept for precision medicine in Parkinson’s disease. This long-term translational research project resulted in the publication of scientific articles in high-impact peer-reviewed journals and the registration of patents at the national and European level. It also led to the set-up of the first inter-institutional infrastructure for early drug discovery between the LCSB and the LIH. “Integrating a wide range of expertise across different disciplines over the past seven years was essential to carry out and finally succeed in this extensive project,” underlines Krüger. “It is a great honour for us to receive such a prestigious award and to turn the spotlight on precision medicine for Parkinson’s disease.”

The project was supported by the FNR through a PEARL grant and the National Centre for Excellence in Research on Parkinson’s disease (NCER-PD). ¢ Watch the Video